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Abstract
The effect of acid-base disturbances on sodium/ proton (Na+ /
H +) exchange has been examined in animal models; however,
few data are available from human studies. To test the effect of
metabolic acidosis on Na+/H+ exchange in man, as well as to
examine the relationship between Na+/H+ exchange and cyto-
solic calcium ([Ca2+1;), we measured both variables in patients
with decreased renal function with mild metabolic acidosis (pH
7.34±0.06), in normal control subjects (pH 7.41±0.02), and in
subjects before (pH 7.40±0.01), and after (pH 7.26±0.04)
ammonium chloride (NH4Cl) 15 g for 5 d. Lymphocytes and
platelets were loaded with the cytosolic pH (pH;) indicator
2'-7'-bis(carboxyethyl)-5,6-carboxyfluorescein and acidified
to pH -6.6 with propionic acid. To quantitate Na+/H+ ex-
change, dpHi/dt was determined at 1 min. [Ca2+ji was mea-
sured with fura-2. Na+/H+ exchange was significantly in-
creased only in lymphocytes of patients with renal insuffi-
ciency. Neither intracellular pH (pH,) nor [Ca2+1i was
different from controls. NH4CI resulted in a significant increase
in Na+/H+ exchange in lymphocytes, but not in platelets of
normal subjects. Values of pHi and [Ca2J1i in either cell type
remained unaffected. Since metabolic acidosis influenced Na+/
H+ only in lymphocytes, but not in platelets, it is possible that
protein synthesis may be involved in increasing Na+/H+ ex-
change. (J. Clin. Invest. 1993.92:858-865.) Key words: Na+/
H + antiporter* lymphocytes * platelets * acidosis * renal failure
Introduction
The Na+/H+ exchanger is an integral membrane protein that
mediates a 1:1 electroneutral exchange ofextracellular Na+ for
intracellular H + ions ( 1, 2). All vertebrate cells investigated so
far contain such an exchange mechanism which regulates cyto-
solic pH (pHi) and cell volume, and which is activated by mito-
genic stimuli and a variety ofhormones ( 1, 2). In renal epithe-
lial cells, two types ofNa+/H+ exchangers exist which are dis-
tinguished by their different sensitivities to amiloride and its
analogues (3). Here, Na+/H+ exchange is also involved in
Na+ and HCO- absorption.
Hypertension and diabetes, which frequently occur con-
comitantly, are characterized by progressive vascular disease,
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the pathogenesis of which may involve Na+/H' exchange by
as yet imperfectly defined mechanisms (4). There is a high
incidence ofboth, which results in, or contributes to, the devel-
opment ofchronic renal failure (CRF).' Subtle disturbances in
acid-base regulation have recently been described in patients
prone to salt-sensitive, essential hypertension (5). An en-
hanced Na'/H + exchange has been well documented in plate-
lets, leukocytes, red blood cells, and skeletal muscle in essential
hypertension, but little is known about the underlying mecha-
nism (for a recent review see reference 6). It is conceivable that
the phenomenon develops as a consequence of other hitherto
unidentified hormonal or metabolic disturbances. Thus, the
definition of factors that modulate Na+/H+ exchange activity
in humans in vivo may also contribute to the understanding of
this abnormality in disease states such as essential hypertension
and diabetes.
While the effects of acid-base disturbances on Na+/H + ex-
change in renal tubular cells of experimental animals have
been studied, few human data are available. We sought to char-
acterize Na+/H+ exchange and pHi regulation in vivo in two
states of metabolic acidosis in man. We first investigated
chronic acidosis in patients with diminished renal function.
Subsequently we investigated the effect of subacute, metabolic
acidosis on Na+/H+ exchange in lymphocytes and platelets
from normal individuals.
Methods
Subject groups and conditions. Due approval and informed consent
were obtained from the normal subjects and patients with renal insuffi-
ciency before the investigations. The protocol was approved by the
University ofErlangen committee for the protection ofhuman subjects
according to the declaration of Helsinki.
Study I: chronic renal acidosis. Blood samples were obtained from
10 male patients with renal insufficiency, each ofwhom had a Cimino-
Brescia fistula placed in preparation for subsequent hemodialysis.
These patients had a variety ofchronic renal diseases (glomerulonephri-
tis, type II diabetes mellitus, hypertensive nephrosclerosis, and analge-
sic nephropathy), but none had type I diabetes mellitus. All were un-
dergoing pharmacological treatment for hypertension. Venous blood
specimens were also obtained from 10 healthy volunteer subjects as
controls. Creatinine, Na', K+, Cl-, HCO-, Pco2, and pH were mea-
sured in serum or plasma as appropriate by automated methods.
Plasma renin activity and plasma aldosterone concentration were mea-
sured by radioimmunoassay (7).
Study II: induced metabolic acidosis in normal volunteers. Eight
normal male volunteers were recruited to participate in a second proto-
col. Arterialized venous blood specimens (8) were obtained for the
variables described above. These blood specimens all had an oxygen
saturation of > 90%. Thereafter, the subjects ingested 30 500-mg
1. Abbreviations used in this paper: BCECF, 2'-7'-bis(carboxyethyl)-
5,6-carboxyfluorescein; CRF, chronic renal failure; EIPA, 5,(N-ethyl-
N-isopropyl)-amiloride; pH,, cytosolic pH.
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NH4Cl capsules in six divided, five-capsule doses for a total of 5 d as
described elsewhere (9). On the morning of the fourth and fifth days,
arterialized venous blood specimens were again obtained. On day 10
blood was again drawn for recovery observations.
Preparation ofplatelet-rich plasma and isolation of lymphocytes.
The blood was anticoagulated by the addition of20% (vol/vol) ofacid
citrate dextrose (85 mM trisodium citrate, 65 mM citric acid, and 11
mM glucose). Platelet-rich plasma was prepared by centrifugation of
blood at 200 g for 15 min at room temperature. The upper two-thirds
of the supernatant was used for preparation of either fura-2
or 2'-7'-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF)-loaded
platelets. The remaining blood was resuspended 1:1 with Hepes-buf-
fered RPMI 1640 medium, pH 7.4. Lymphocytes were prepared after
centrifugation ofblood on a Ficoll gradient ( 10). Inspection of stained
cell smears revealed that lymphocyte preparations were composed of
90% lymphocytes and 10% monocytes.
Measurement ofpHi. Cytosolic pH was determined using the fluo-
rescent pH indicator BCECF. Pelleted platelets were resuspended in
Hepes buffer consisting of 140 mM NaCl, 5 mM KCl, 5 mM KH2PO4,
1 mM MgSO4, 10 mM Hepes (free acid), and 5 mM glucose, pH 6.5
(at 37°C). 10 AtM BCECF-AM (final concentration; Molecular Probes,
Inc., Eugene, OR) was added, and the cells were incubated for 30 min
at 37°C. Thereafter, 1 ,uM PGI2 was added and the cells were washed
twice in Hepes buffer, pH 6.5, by repeated centrifugation. The final
platelet pellet was resuspended in Hepes buffer, pH 7.4, at a concentra-
tion of 5 X 109 cells/ml. 100-pi aliquots of these suspensions were
transferred to 2 ml of Hepes buffer in a cuvette and prewarmed at
37°C. All measurements were conducted within 1 h after loading. Dur-
ing this time leakage of BCECF did not exceed 10% as assessed by
comparison of fluorescence of platelets and corresponding superna-
tants and was, therefore, neglected.
Lymphocytes were incubated with 10 ,uM BCECF-AM for 30 min
at 37°C in RPMI 1640 medium and washed twice in this medium by
repeated centrifugation. Before prewarming to 37°C, aliquots of lym-
phocytes were briefly spun down in an Eppendorf centrifuge and then
resuspended into Hepes buffer before being used for fluorescence mea-
surements (final concentration I X 103 cells/,ul). This procedure effi-
ciently removes extraneous dye. Leakage of dye during prewarming
was < 10% and was therefore not corrected. The fluorescence of
BCECF was recorded under constant stirring using aKONTRON SFM
24 spectrofluorimeter (Kontron, Dusseldorf, FRG) equipped with a
thermostatted cuvette holder. Wavelengths for excitation and emission
were set to 495 and 530 nm, respectively. Calibration of the BCECF
signals in terms of pH1 was performed using the high K+/nigericin
method ( 11).
Determination ofNa+/H+ exchange activity. Na+/H+ exchange
was activated by addition of various amounts of Na+-propionate or
K+-propionate solution (final concentrations 10-50 mM) from a 1-M
stock solution, pH 7.4, exactly as described recently ( 12). Recovery of
pHi in lymphocytes (Fig. 1 A) was inhibited by > 90% in the absence of
extracellular sodium (Fig. 1 B) and by 95% at 10 ,uM of the specific
inhibitor 5-(N-ethyl-N-isopropyl)-amiloride (EIPA; Fig. 1 C). Both
findings suggest that pHi recovery was almost exclusively mediated by
Na+/H + exchange. Osmotic activation ofthe antiport by 50mM propi-
onate appeared unlikely, as a challenge of cells by 50 mM NaCl failed
to affect pHi (Fig. 1 D). Identical observations were made in platelets
(not shown).
Initial rates of EIPA-sensitive pHi recovery were calculated as de-
scribed in detail recently (12) and are expressed as dpHi/min. The
relationship between pHi and pHi recovery could best be described by a
sigmoidal function as detailed earlier ( 12). Parameters calculated from
fitting experimentally derived data to a sigmoidal function allowed the
calculation of apparent Vmax values (see reference 12 for full detail.)
It is well known that exact characterization ofthe antiport's kinetic
parameters can only be achieved by the nigericin pHi clamp method(13) or by the NH4Cl prepulse method. Determination of true Vmax
requires acidification to pHi 6.0, whereas with propionate acidification
beyond pHi 6.6 (at pHO 7.4) cannot be achieved. Furthermore, pH1
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Figure 1. Representative fluorescence recordings from BCECF-loaded
human lymphocytes. Displayed are typical recordings obtained from
BCECF-loaded lymphocytes suspended in Hepes buffer, pH 7.4, at
370C. (A) Effect of addition of Na' propionate (50 mM, final con-
centration; arrow). Lymphocytes were suspended in buffer containing
150 mM Na'. (B) Lymphocytes were suspended in Na'-free buffer
(NaCl isoosmotically replaced by choline chloride) and acidified by
addition of 50 mM K+ propionate (arrow). (C) Effect of EIPA (10
,qM) on pHi recovery. Lymphocytes suspended in buffer containing
150 mM Na' were acidified by addition of 50 mM Na' propionate
(arrow). (D) Effect of addition of NaCl on pHi. Lymphocytes sus-
pended in Na'-containing buffer were challenged with 50 mM NaCl
(final concentration; arrow). The initial decrease in BCECF fluores-
cence is a dilution artifact. No further change in fluorescence occurred
during 6 min. Similar results were obtained in BCECF-loaded plate-
lets in response to identical experimental maneuvers (not shown).
recovery rates are dampened and the original baseline pH is not re-es-
tablished due to the continuous influx of propionic acid. A full discus-
sion of the limitations of this method can be found elsewhere ( 12).
However, we wished to examine antiport activity and cytosolic free
Ca2+ in two cell specimens from one individual at the same occasion,
which requires fast experimental procedures. This renders application
of the nigericin pHi clamp method impossible, as this technique is time
consuming. It is conceivable that prolonged storage of blood may affect
antiport activity and/or Ca2'i . Finally, neither the nigericin pHi clamp
technique nor the NH4Cl prepulse method can be applied to platelets,
as these techniques require one or more centrifugation steps. In plate-
lets this is possible only in the presence of agents that raise cAMP, or at
acidic extracellular pH, in order to prevent any preactivation or aggre-
gation of these cells. Since these manipulations might have caused un-
foreseen effects on antiport activity, we preferred to use acidification by
propionate, which enabled us to apply the same procedure to both
blood cell types. Finally, all these potential confounders are present to a
similar extent in the cells of control subjects, patients with renal failure,
and volunteers on whom metabolic acidosis was imposed. This notion
is also supported by the evaluation of the immediate effects of propio-
nate addition on pHi in platelets and lymphocytes under the various
(patho-) physiological states investigated. In any event, it can be stated
that identical amounts of Na+ propionate produced similar acidifica-
tion in all individuals, whereas only pHi recovery rates were signifi-
cantly different (see Results).
Determination of [Ca2+]i. Intracellular free calcium was deter-
mined after loading platelets with the fluorescent dye fura-2-AM essen-
tially as described earlier ( 14). Lymphocytes were loaded with 2 ALM
fura-2-AM for 1 h at room temperature in RPMI 1640 medium. After
two washing steps in the same medium cells were resuspended at a
density of 1 X 106 cells/ml. Samples were briefly spun down in an
Eppendorf centrifuge before they were added to a cuvette containing
Hepes buffer. In that way we minimized the contribution of leaked
fura-2 to the measured fluorescence. Fluorescence was measured in
thermostatted (37°C) cuvettes with continuously stirred buffer at 339
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Table I. Plasma Electrolytes and Acid-Base Values ofNormal
Subjects and Patients with Renal Insufficiency
Patients with
Normal subjects renal insufficiency
Creatinine (mg/dl) 0.9±0.14 6.4±0.71*
Na' (mmol/liter) 140±2 139±1
K+ (mmol/liter) 4.4±0.3 4.5±0.5
C1- (mmol/liter) 103±3 104±2
HCO- (mmol/liter) 28±1.3 21±3.3*
pH 7.41±0.02 7.34±0.06*
Pco2 (mmHg) 44±2.7 37±1.7*
Values represent means ± SD of 10 normal controls and 10 patients
with renal insufficiency. * Significantly different from controls at
P < 0.05.
nm for excitation and 505 nm for emission, respectively. Calibration of
fluorescence in terms of [Ca2" J was performed as described by Pollock
et al. ( 15).
Presentation ofdata. Unless stated otherwise, data are expressed as
means±SD. Comparison between data was made by unpaired (patients
and normal subjects) or paired (subjects before and after NH4Cl-in-
duced metabolic acidosis) two-sided t tests. Differences were assumed
to be significant at P < 0.05.
Results
Study I: chronic renal acidosis
Clinical parameters and acid-base status ofpatients with renal
insufficiency. In Table I are shown serum creatinine, Na', K+,
and ClP, as well as plasma pH, Pco2, and HCO- of normal
subjects and patients with CRF. Plasma pH, Pco2, and HCO3
values were significantly lower in the patients, while creatinine
values were higher, compared with the normal subjects.
Na+/H+ exchange and [Ca2+]i. In Fig. 2 are shown pH,
recovery rates in control and CRF in both lymphocytes and
platelets. The lowest values ofpHi achieved by propionate acidi-
fication did not exceed pH, 6.6; i.e., true vma, values, which
require acidification to pHi 6.0, could not be determined by
our technique (cf. Methods). Nevertheless, it is evident that
lymphocytes from patients (Fig. 2 B) displayed distinctly en-
hanced pHi recovery rates compared with those from controls
(Fig. 2 A). The parameters of the fitted lines through the
pooled data from all individuals yielded an apparent v., ofthe
Na+/H+ exchanger of 0.053 dpHi/min in controls (Fig. 2 A)
and a value of0.079 in patients (Fig. 2 B). Apparent half-maxi-
mum activation occurred at pHi 6.84 in controls and at pHi
6.80 in patients, respectively. Hence, the increase in apparent
v~n in the lymphocytes of patients was not accompanied by an
alkaline shift in the Na+/H+ exchanger activation curve. In
contrast, no such difference in vm,, was noticeable when plate-
lets of controls (Fig. 2 C) and patients (Fig. 2 D) were com-
pared. The parameters of the fitted sigmoidal function yielded
values for apparent v. of0.086 and 0.096 dpHi/min in con-
trols and patients, respectively. Thus, although the Na+/H+
exchanger appeared to be slightly enhanced also in platelets of
patients with renal insufficiency, this difference was not statis-
tically significant (see below). Apparent half-maximum acti-
vation ofthe antiport occurred at pHi 6.86 and 6.84 in controls
and patients, these values being again not significantly dif-
ferent.
To display the scatter of apparent vm,, values in different
subjects, individual pHi recovery rates in lymphocytes of con-
trols and patients are shown in Fig. 3 A. In controls, mean pH1
recovery averaged 0.056±0.02 dpH1/min. In CRF, pHi recov-
ery averaged 0.091±0.013 dpH1/min. This latter value is signif-
icantly different from that of controls (P = 0.0005). Basal pHi
values in lymphocytes of controls and patients (Fig. 3 B) aver-
aged 7.01±0.09 and 6.97±0.08 and were, hence, not signifi-
cantly different (P = 0.2). Fig. 3 C displays the immediate
change in pHi from basal (- ApHi) evoked by addition ofiden-
tical amounts of propionic acid (final concentration 50 mM)
in lymphocytes ofcontrols and patients. Under otherwise iden-
tical conditions, i.e., similar values of pHi and pH., these val-
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Figure 2. Nal/H+ exchange activity in
lymphocytes and platelets in healthy
subjects and patients with CRF. Shown
are pHi recovery rates (dpH /min) at
different values of pHi achieved by
acidification of lymphocytes (A, B) and
platelets (C, D) with Na+-propionate
( 10-50 mM) in healthy subjects (A, C)
and patients with renal insufficiency
(B. D). In each panel pooled data from
10 individuals are displayed. The lines
were obtained after fitting the data to a
sigmoidal function (see reference 12).
o, lymphocytes; ,, platelets; open sym-
bols, controls; closed symbols, patients.
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370C. (C) Acidification by 50 mM Na'-propionate of lymphocytes of controls (C) and patients (CRF). Values represent the initial immediate
decrease in pHi ( - ApHj) after the addition of Na+-propionate. At identical pH. and similar pHi (cf. B) these values are a reflection of the
cytosolic buffer capacity for H+.
ues are a rough reflection of the cytosolic buffer capacity for
H'. Basal pHi in controls and patients decreased by 0.33±0.09
and 0.33±0.05 pH units (P = 0.9), respectively. Therefore, the
distinct enhancement ofNa+/H' exchange in lymphocytes of
patients with renal failure cannot be attributed to an alkaline
shift in basal pHi of the antiport (which would be excepted if
the enhancement were due to agonist stimulation of these
cells), or to changes in the cytosolic buffer capacity for H+.
Platelets, on the other hand, displayed much higher pHi
recovery rates than lymphocytes, perhaps due to their more
favorable surface to volume ratio (Fig. 4 A). Mean individual
apparent vm0 values were not different in controls and patients
(P = 0.34) and averaged 0.082±0.022 and 0.089±0.014 dpHi/
min, respectively. There was a marginal tendency for more
alkaline basal pHi values in platelets compared with lympho-
cytes, and means were 7.09±0.04 and 7.07±0.05 in controls
and patients, respectively (Fig. 4 B). Again, acidification by 50
mM propionate induced an identical fall in pH, by 0.32±0.04
and 0.33±0.04 in controls and patients, respectively, suggest-
ing no change in the buffer capacity in platelets of CRF pa-
tients.
To investigate whether or not the enhanced Na+/H+ ex-
change in lymphocytes of patients with CRF would coincide
with elevated values of [Ca2+]i, this parameter was also deter-
mined in both blood cell types of controls and patients. In
lymphocytes, the mean [Ca2+]i amounted to 74.3±9.4 (n =
10) and 71.2±22.4 nM (n = 10) in controls and patients, re-
spectively. In platelets the mean [Ca2+ ]i values were 121 ± 19 (n
= 10) and 1 19±14 nM (n = 10) in controlsandpatients, respec-
tively. Thus, we conclude that the enhancement of Na+/H'
exchange in lymphocytes of patients with renal insufficiency is
not associated with a parallel rise in [Ca2 ]i in these cells.
Study II: induced metabolic acidosis in normal volunteers
Clinical parameters and acid-base status of normal subjects
with or without NH4Cl. This study was performed to investigate
whether or not the enhancement ofNa'/H+ exchange seen in
lymphocytes of patients with CRT was predominantly due to
the simultaneously prevailing chronic metabolic acidosis. This
state was achieved by inducing short-term (5 d) metabolic aci-
dosis in normal healthy volunteers with NH4Cl. Table II dis-
plays values for Na+, K+, Cl-, pH, Pco2, and HCO- before
and after administration of NH4Cl for 5 d. Plasma pH, Pco2,
and HCO- decreased significantly in response to NH4Cl,
whereas Cl- increased concomitantly. Body weight decreased
by 2 kg compared with baseline values. Systolic blood pressure
did not change; a borderline increase in diastolic blood pres-
sure (0.05 < P < 0.01 ) was observed. The plasma renin activity
and plasma aldosterone concentrations increased significantly.
The 24-h urine Na+ excretion was not different, while urine K+
excretion, urine Cl- excretion, urine Ca2' excretion, and urine
urea excretion were increased compared with baseline values.
No effect on the clearance of creatinine was observed.
Na+/H+ exchange and [Ca2`]i in blood cells of healthy
volunteers with or without NH4Cl. Fig. 5 displays typical activa-
tion curves of the antiport in lymphocytes of eight subjects
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Figure 4. pH1 recovery, basal pHi, and esti-
mate of buffer capacity in platelets ofcon-
trols and patients with CRF. (A) Displayed
are individual apparent maximum pHi re-
covery rates (dpHi/min) in platelets of 10
controls (C) and of 10 patients with CRF.
(B) Basal pHi values in platelets of controls
(C) and patients (CRF) obtained in
HCO--free Hepes buffer, pH 7.4, at 370C.
(C) Acidification by 50 mM Na'-propio-
nate of platelets of controls (C) and pa-
tients (CRF). Values represent the initial
immediate decrease in pHi (- ApHj) after
the addition of Na'-propionate. At identi-
cal pH. and similar pHi (cf. B) these values
reflect the cytosolic buffer capacity for H .
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Table II. Effects ofNH4Cl on Plasma Acid-Base Values, Body
Weight, Blood Pressure, Plasma Renin Activity, Plasma
Aldosterone, Creatinine Clearance, Urine Urea,
and Urine Electrolyte Excretion in Normal Subjects
Control NH4CI
Na (mmol/liter) 140±2 137±3
K (mmol/liter) 4.4±0.4 4.4±0.3
Cl (mmol/liter) 103±3 116±4*
HCO- (mmol/liter) 27±0.8 13±1.7*
pH 7.4±0.01 7.26±0.04*
Pco2 (mmHg) 39±1.7 28±0.9*
BWT (kg) 72.2±5.1 70.2±5.6*
Systolic BP (mmHg) 126±10 128±8
Diastolic BP (mmHg) 75±4 84±7
PRA (ng Ang 1/h) 1.67±0.75 13.49±10*
PA (ng/100 ml) 62.17±57 386±567*
ClCr (ml/min) 116±11 128±27
UureaV (mg/24 h) 2,359±773 3,176+712*
UNaV (mmol/24 h) 160±42 169±91
UKV (mmol/24 h) 67±33 138±32*
UCIV (mmol/24 h) 167±33 390±73*
UCaV (mmol/24 h) 5.2±0.6 14.2±2.01*
All data are means ± SD from eight individuals before and after
NH4Cl treatment. * Significantly different from control at P < 0.05.
BWT, body weight; BP, blood pressure; PRA, plasma renin activity;
PA, plasma aldosterone concentration, ClCr, creatinine clearance;
UureaV, urine urea excretion; UNaV, urine Na+ excretion; UKV,
urine K+ excretion; UCIV, urine C1- excretion; UCaV, urine Ca2"
excretion.
before, during, and after metabolic acidosis induced by NH4Cl
ingestion. On day 1 (control; Fig. 5 A), the sigmoidal fit
through the data points yielded an apparent vm. ofthe antiport
of0.45 dpHi/min and apparent half-maximum activation was
attained at pHi 6.94. On day 4 of NH4Cl treatment (Fig. 5 B)
these values were 0.084 dpHi/min and 6.85, respectively.
Lymphocyte Na+/H+ exchange activity normalized on day
10, i.e., 5 d after the release from NH4C1 treatment (Fig. 5 C),
and apparent vn,,. and pHi for half-maximum activation were
calculated at 0.06 pHi/min and 6.83, respectively. Fig. 6 shows
calculated apparent vm.. values of the lymphocyte Na+/H+
exchanger for all individuals enrolled. It is evident that Na+/
H+ exchange activity in lymphocytes increased in all but one
subject during NH4Cl ingestion (days 4 and 5) and returned to
control values 5 d after the release from treatment (day 10).
Before treatment (day 1 ) v,, averaged 0.06±0.02 dpHi/min.
On day 4 this value increased significantly to 0.10±0.04 dpHi/
min (P < 0.025). On day 5 antiport activity in lymphocytes
remained elevated at 0.09±0.03 dpHi/min. This value was
again significantly different from that of day 1 (P < 0.05) but
not different from that of day 4. On day 10 apparent v. nor-
malized to 0.06 dpHi/min, this value being indistinguishable
from that ofcontrol, i.e., day 1. No change in lymphocyte basal
pHi was seen before, during, or after NH4Cl-induced acidosis,
and values averaged 7.03±0.07, 7.03±0.06, 7.03±0.09, and
7.04±0.05 on days 1, 4, 5, and 10, respectively. Furthermore,
enhancement ofthe lymphocyte antiport seemed not to be due
to changes in the buffer capacity for H+, since addition of 50
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Figure 5. Effect of
NH4CI-induced meta-
bolic acidosis on Na+/
H+ exchange rates in
lymphocytes. In each
panel are displayed
7.2 pooled pHi recovery
rates (dpHi/min) from
lymphocytes of eight
individuals. Lines were
obtained by fitting the
experimentally derived
data to a sigmoidal
function. (A) Control
before NH4C1 treat-
ment; (B) day 4 of
7.2 NH4Cl ingestion; (C) 5
d after release from
NH4C1 treatment.
mM propionate caused the same degree of acidification on
days 1, 4, 5, and 10 and pHi decreased by 0.34±0.08,
0.36±0.05, 0.33±0.04, and 0.34±0.09 U, respectively. Hence,
NH4Cl-induced metabolic acidosis in healthy volunteers appar-
ently evoked an almost twofold enhancement ofNa+/H+ ex-
change in lymphocytes, comparable to that of patients with
CRF, without major changes in the buffer capacity for H+ or
an alkaline shift in the antiport's activation curve.
The effect of metabolic acidosis on platelet Na+/H+ ex-
change activity is displayed in Fig. 7. In control (Fig. 7 A)
apparent v.,, was calculated at 0.066 dpHi/min and this value
did not significantly change on day 4 of NH4C1 treatment
(0.076 dpHi/min; Fig. 7 B). On day 10, apparentv, was 0.71
dpHi/min. Individual apparent v. values ofthe platelet anti-
port before (day 1), during (days 4, 5), and after (day 10)
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Figure 6. Changes in Na+/H+ exchange activity in lymphocytes dur-
ing NH4CI-induced metabolic acidosis. Displayed are pHi recovery
rates (dpHi/min) in lymphocytes before (day 1), during (days 4 and
5), and 5 d after NH4Cl ingestion (day 10). Each symbol represents
one individual.
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Figure 7. Effect of
NH4Cl-induced meta-
bolic acidosis on Na+/
H + exchange rates in
platelets. In each panel
are displayed pooled
pHi recovery rates
(dpHi/min) from
platelets of eight indi-
viduals. (A) Control be-
fore NH4Cl treatment;
(B) day 4 of NH4C1 in-
gestion; (C) 5 d after
release from NH4CI
treatment.
NH4Cl-induced metabolic acidosis are shown in Fig. 8. vm.,
values were 0.068±0.017, 0.071±0.02, 0.08±0.04, and
0.074±0.014 dpHi/min on days 1, 4, 5, and 10, respectively,
and hence not significantly different. Basal pHi and the acidifi-
cation from basal pHi by 50mM propionate were also identical
on all days.
We also determined basal values of [Ca2+]i in platelets and
lymphocytes at day 5 of NH4Cl treatment and under control
conditions. Mean values in lymphocytes and platelets were
73±19 and 122±17 nM, respectively. These values were again
not significantly different from those of the untreated control
condition (76±17 and 18±15 nM).
Discussion
Na+/H+ exchange in lymphocytes and platelets in CRF. We
report here that lymphocyte but not platelet Na+/H+ exchange
activity is significantly enhanced by a factor of - 1.6 in cells
from patients with CRF compared with those from controls
(Figs. 2-4). Thus we will first briefly discuss the mechanism(s)
potentially mediating this behavior. The most trivial cause of
an enhanced pHi recovery from acidification might be a reduc-
tion in the intracellular buffer capacity for H' in CRF. How-
ever, as identical amounts of propionate induced identical ini-
tial acidification in platelets and lymphocytes of controls and
patients (Figs. 3 and 4), this explanation can largely be ruled
out. Furthermore, under our assay conditions (no HCO ) the
buffer capacity is predominantly determined by the total cyto-
solic protein concentration. It appears unlikely that an almost
twofold enhancement ofpHi recovery in lymphocytes is due to
a corresponding 50% reduction in cytosolic protein concentra-
tion. In addition, other investigators have also determined un-
4 5 10
Day
Figure 8. Changes in Na+/H' exchange activity in platelets during
NH4C1-induced metabolic acidosis. Displayed are pHi recovery rates
(dpHi/min) in platelets before (day 1), during (days 4 and 5), and
5 d after NH4Cl ingestion (day 10). Each symbol represents one in-
dividual.
changed ( 16) or even increased ( 17) buffer capacities in white
blood cells ofCRF patients.
Activation ofthe Na+/H+ exchanger can occur after stimu-
lation of cells by a wide variety of hormones (2). In most cells
this enhancement of transport activity involves an alkaline
shift of the antiport's setpoint, i.e., the pH value above which
the transporter is silent ( 1 ). However, despite an enhanced pHi
recovery neither baseline pHi nor the pHi value at which half-
maximum activation occurred were significantly shifted in
lymphocytes of CRF patients. Although circumstantial, this
may serve as an argument against prestimulation by circulating
agonists as the major cause of the enhancement of Na+/H'
exchange. Furthermore, since average [Ca2+ ]i was not different
in the lymphocytes of controls and patients, an elevation of
[Ca2+]i also appears unlikely to mediate the distinct enhance-
ment ofNa+/H+ exchange. Therefore, other underlying mech-
anisms (e.g., an increased amount of antiporter protein) must
be taken into consideration (see below). Although speculative,
this would also explain why Na+/H + exchange is not acceler-
ated in platelets ofCRF patients, since these cells lack a nucleus
and are therefore unable to newly synthesize antiport protein.
One might wonder why basal pHi was not lowered in plate-
lets and lymphocytes ofpatients compared with controls, since
plasma pH was also significantly reduced in CRF. However, it
should be emphasized in this context that our pHi determina-
tions were conducted at an extracellular pH of 7.4 in HCO3-
free buffer. It is conceivable that cell pHi might be acidic in
patients under in vivo conditions.
Na+/IH exchange in lymphocytes during NH4Cl-induced
metabolic acidosis. The main objective oftreating healthy sub-
jects with NH4Cl was to answer the question whether the en-
hancement of Na+/H+ exchange observed in lymphocytes of
CRF patients could be reproduced by simply imposing meta-
bolic acidosis on these subjects. Thus, these otherwise healthy
individuals were expected to display some ofthe abnormalities
found in CRF patients, e.g., changes in plasma acid-base status
and electrolyte composition and, potentially, similar acidosis-
related alterations in blood hormone composition, but were
devoid of uremia-related changes in metabolism. In fact, acid-
base status and electrolytes (except Cl -) were similar in CRF
and during NH4CI-induced metabolic acidosis (cf. Tables I
and II).
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The subjects noted some lassitude, but otherwise had no
subjective side effects from NH4Cl, which at higher doses may
cause quite profound effects primarily related to acidosis ( 18).
Body weight decreased by 2 kg, which we attributed to diuresis
and natriuresis. Urine Na' excretion was not increased on day
5; however, it is likely that Na+ balance was reachieved by that
time; the tl2 of Na' balance is 1.5 d (19). We were sur-
prised that blood pressure did not decrease. The sharp increase
in renin and aldosterone values may have contributed to main-
tain blood pressure. The increased renin secretion may have
been related to volume losses as reflected by body weight. The
substantial amounts of Cl- ions delivered to the distal tubule
would be expected to decrease rather than increase renin re-
lease. Kotchen et al. (20) have emphasized the role of Cl-
delivery to the thick ascending portion ofHenle's loop in signal-
ing renal renin release. They found that increased Cl - delivery
reduced renin release. A brisk kaliuresis ensued after NH4Cl
administration. Serum K+ values were not changed, suggesting
that cytosolic K+ concentrations may have decreased. Total
body potassium depletion is known to increase renin release
(21). An increased urea synthesis and calciuresis are recog-
nized features of NH4Cl administration ( 18).
Na+/H+ exchange activity was accelerated in lymphocytes
during metabolic acidosis and it appears that this enhancement
(Fig. 5 B) was strikingly similar to that observed in CRF pa-
tients (Fig. 2 B). The reversibility of this enhancement also
appears noteworthy and NaI/H+ exchange activity normal-
ized in all subjects 5 d after the termination of NH4Cl treat-
ment (Fig. 5 C). Furthermore, it should be emphasized that
NH4Cl ingestion enhanced the lymphocyte Na+/H' ex-
changer in all individuals examined, albeit to a different degree
(Fig. 6). In one individual pHi recovery was apparently higher
before treatment with NH4Cl. However, we believe that this
might reflect an experimental artifact rather than a true inverse
behavior ofantiport activity. The results depicted in Fig. 6 may
also serve to underline the validity ofthe propionate technique
for estimation of Na+/H+ exchange activity despite its well-
known and already discussed limitations (cf. Methods). It can
be clearly seen that the rates ofpH, recovery are very similar on
days 4 and 5 of metabolic acidosis and during control (days 1
and 10), suggesting that our results were quite reproducible.
We found again that the enhancement of Na+/H+ exchange
during metabolic acidosis was not accompanied by an alkaline
shift of basal pHi ex vivo, which again may argue against pre-
stimulation ofthe cells. Furthermore, as the buffer capacity for
H+ and [Ca2+]i remained unaffected during NH4Cl ingestion,
these parameters are unlikely to contribute to the acceleration
of the lymphocyte antiporter during metabolic acidosis.
In contrast, platelet Na+/H+ exchange activity was not sig-
nificantly accelerated in metabolic acidosis in any of the indi-
viduals investigated. This observation was similar to that made
in the CRF patients.
Taken together, Na+/H+ exchange is elevated in lympho-
cytes but not in platelets ofpatients with CRF, and the fact that
this phenomenon could be reproduced in healthy volunteers
after the ingestion ofNH4C1 may suggest that in fact metabolic
acidosis, but not other uremia-related abnormalities in CRF,
mediate this enhancement.
The major issue is whether the enhancement of Na+/H+
exchange in blood cells is a direct result ofmetabolic acidosis in
patients with renal failure and NH4Cl-treated volunteers, i.e., a
direct consequence of reduced plasma pH (and, potentially,
reduced pHi in vivo), or whether metabolic acidosis causes
other hormonal changes that in turn activate the Na'/H+ ex-
changer. Some arguments may favor the notion that it is the
fall in pHi that directly activates the Na+/H + exchanger, possi-
bly by increasing the amount of exchanger protein in the
plasma membrane. CRF is characterized by long-term meta-
bolic acidosis. Krapf et al. (22) have shown that in rats meta-
bolic but not respiratory acidosis induces an increase in anti-
port mRNA in kidney cortex. Moe et al. (23, 24) were able to
confirm that mouse renal cortical tubule cells and an opossum
kidney cell line responded to a 24-h in vitro metabolic acidosis
with an almost twofold increase in Na+/H+ exchange activity
that was accompanied by a threefold increase in antiport
mRNA. These results could be confirmed by feeding rats with a
diet that induced metabolic acidosis. Fibroblasts, on the other
hand, responded with a slight, albeit significant reduction in
antiport activity in response to acidosis, which was paralleled
by a reduction of antiport mRNA abundance (24). Although
details involving this behavior remain unexplained, the con-
clusion remains that acid preincubation may enhance antiport
synthesis in some cells and tissues.
We are currently investigating whether or not NH4Cl-in-
duced metabolic acidosis increases the steady-state concentra-
tion ofantiportmRNA in lymphocytes using quantitative poly-
merase chain reaction. Preliminary results indicate that anti-
port mRNA is in fact increased in metabolic acidosis by a
factor of - 1.5 above normal (Siffert, W., unpublished obser-
vations). This finding would also explain why metabolic acido-
sis enhances Na+/H+ exchanger only in nucleated lympho-
cytes but not in platelets, as these latter nonnucleated blood
components are not capable of protein synthesis.
In summary, we present the first observations in man sug-
gesting that Na+/H + exchange is important in the regulation of
pHi under the condition of short-term and chronic metabolic
acidosis. They suggest that pHi is well regulated even in the face
of metabolic acidosis. The homeostatic adjustments in pHi reg-
ulation and the regulation ofNa'/H+ exchange in other clini-
cal acid-base disturbances and the effects of therapeutic inter-
ventions remain to be elucidated.
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